Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BAROSTIM NEO® System
DEVICE
2 trials
Sponsors
CVRx, Inc.
Conditions
Heart Failure
Unknown Phase
BAROSTIM® Hope for Heart Failure Study
NCT01720160
CVRx, Inc.
Heart Failure
Start: 2012-11-30
End: 2021-03-31
Updated: 2019-05-14
Baroreflex Activation Therapy for Heart Failure
Completed
NCT02627196
CVRx, Inc.
Heart Failure
Start: 2016-04-19
End: 2023-10-01
Updated: 2026-03-10
Related Papers
Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure.
2021-05-12
8 citations
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology
2020-06-29
191 citations
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
2018-04-21
20 citations
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction
JACC Heart Failure
2015-05-13
276 citations